Most Recent
A joint venture which helped design the Melbourne Metro has filed a $50 million lawsuit claiming they were not given enough of a $1.37 billion payout promised by the state's government to cover additional work.
A Sydney-based plastic surgeon with more than 5 million followers on TikTok has taken the ABC to court to block an upcoming episode of Four Corners about him from running.
AMP has taken the insurance arm of Willis Towers Watson to court to try to force it to stick to an alleged promise to rent two floors in a central Sydney commercial block that was made just before the start of the COVID-19 pandemic.
The manufacturer of the popular 1000Hour Lash & Brow Dye has accused “luxe-for-less” cosmetics company MCoBeauty of infringing its trade mark with its new 2000 Hour Lash & Brow Tint and misrepresenting to consumers that the product lasts twice as long.
A court has dismissed challenges to the New South Wales public health orders that made it mandatory for certain workers to be vaccinated against COVID-19, declaring they did not breach workers’ rights to bodily integrity.
This week's judgment referring the conduct of lawyers behind the Banksia class action to prosecutors shows the effectiveness of unique legislative provisions in Victoria that should serve as a blueprint for federal reform, says barrister and University of New South Wales adjunct professor Dr Peter Cashman.
The former CEO of failed coconut water venture CoCo Joy, which once sponsored the Manly-Warringah Sea Eagles NRL team, faces charges he managed the company while disqualified due to bankruptcy.
Mining magnate Clive Palmer and two of his mining firms have lost a High Court challenge seeking to overturn a Western Australian law which prevented him from suing the state government for $30 billion over mining tenements in the Pilbara.
A class action over a public housing lockdown during Melbourne's second COVID-19 wave in July last year is seeking to discontinue battery and negligence claims against the Victorian government, a court has heard.
Botox drug maker Allergan has secured an injunction against a Sydney-based cosmetics company which sought to “leverage” the reputation of the well-known injectable to sell its Freezeframe line of anti-aging topical creams.